Abstracts

Geier 2015 – Thimerosal: Clinical, epidemiologic and biochemical studies

Geier 2014 – A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopment Disorders

Geier 2014 – A Case-Control Study Evaluating the Relationship Between Thimerosal-Containing Haemophilus influenza Type b Vaccine Administration and the Risk for a Pervasive Developmental Disorder Diagnosis in the United States

Geier 2014 – The risk of neurodevelopment disorders following a Thimerosal-preserved DTaP formulation in comparison to its Thimerosal-reduced formulation in the vaccine adverse event reporting system (VAERS)

Geier 2013 – A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States

Geier 2012 – Hair Toxic Metal Concentrations and Autism Spectrum Disorder Severity in Young Children

Geier 2010 – Blood mercury levels in autism spectrum disorder: Is there a threshold level?

Geier 2009 – Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure in thimerosal and other metal compounds

Geier 2008 – Biomarkers of environmental toxicity and susceptibility in autism

Geier 2008 – A Prospective Study of Transsulfuration Biomarkers win Autistic Disorders

Geier 2007 – A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders

Geier 2007 – A Prospective Study of Mercury Toxicity Biomarkers in Autistic Spectrum Disorders

Geier 2007 – A Case Series of Children with Apparent Mercury Toxic Encephalopathies Manifesting with Clinical Symptoms of Regressive Autistic Disorders

Geier 2007 – An Evaluation of the Effects of Thimerosal

Geier 2006 – A meta-analysis epidemiological assessment of neurodevelopment disorders following vaccines administered from 1994-2000 in the United States

Geier 2006 – Early Downward Trends in Neurodevelopment Disorders Following Removal of Thimerosal-Containing Vaccines

Geier 2004 – Neurodevelopmental Disorders Following Thimerosal-Containing Childhood Immunizations: A Follow-Up Analysis

Geier 2004 – A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism

Garrecht 2011 – The plausibility of role for mercury in the etiology of autism: a cellular perspective

Gallagher 2010 – Hepatitis B Vaccination of Male Neonates and Autism Diagnoses, NHIS 1997-2002

El-baz – Hair mercury measurement in Egyptian autistic children

Duszczyk-Budhathoki 2012 – Administration of Thimerosal to Infant Rats Increases Overflow of Glutamate and Aspartate in the Prefrontal Cortex: Protective Role of Dehydroepiandrosterone Sulfate

Deth 2007 – How environmental and genetic facts combine to cause autism: A redox/methylation hypothesis

DeSoto 2007 – Blood Levels of Mercury Are Related to Diagnosis of Autism: A Reanalysis of an Important Data Set

Chrysochoon 2003 – An 11-month-old boy with psychomotor regression and auto-aggressive behavior

Burbacher 2005 – Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal

Bradstreet 2003 – A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders

Blaucok Busch 2012 – Efficacy of DMSA Therapy in a Sample of Arab Children with Autistic Spectrum Disorder

Blanusa 2012 – Mercury Disposition in Suckling Rats: Comparative Assessment Following Parenteral Exposure to Thimerosal and Mercuric Chloride

Bernard 2002 – The role of mercury in the pathogenesis of autism